Department of Pathology, School of Medicine and Health Sciences, University of North Dakota, 501 N. Columbia Road, Grand Forks, ND, 58202, USA.
This laboratory has generated a series of seven cadmium (Cd+2)- and six arsenite (As+3)-transformed urothelial cancer cell lines by exposure of parental UROtsa cells to each agent under similar conditions of exposure. In this study, the seven Cd+2-transformed cell lines were characterized for the expression of keratin 6, 16, and 17 while the six As+3 cell lines were assessed for the expression of keratin 7 and 19. The results showed that the series of Cd+2-transformed cell lines and their respective transplants all had expression of keratin 6, 16, and 17 mRNA and protein. The expression of keratin 6, 16, and 17 was also correlated with areas of the urothelial tumor cells that had undergone squamous differentiation. The results also showed that four of the six As+3-transformed cell lines had expression of keratin 7 and 19 mRNA and protein and produced subcutaneous tumors with intense focal staining for keratin 7 and 19. The other two As+3-transformed cell lines had very low expression of keratin 7 mRNA and protein and produced subcutaneous tumors having no immunoreactivity for keratin 7; although keratin 19 expression was still present. The peritoneal tumors produced by one of these two cell lines regained expression of keratin 7 protein. The present results, coupled with previous studies, indicate that malignant transformation of UROtsa cells by Cd+2 or As+3 produce similar patterns of keratin 6, 7, 16, 17, and 19 in the resulting series of cell lines and their respective tumors.
Written by:
Somji S, Cao L, Mehus A, Zhou XD, Sens MA, Dunlevy JR, Garrett SH, Zheng Y, Larson JL, Sens DA. Are you the author?
Reference: Cell Biol Toxicol. 2011 Sep 17. Epub ahead of print.
doi: 10.1007/s10565-010-9169-z
PubMed Abstract
PMID: 21927821
UroToday.com Investigational Urology Section
